Pharmagreen Biotech Inc. (PHBI)

OTCMKTS · Delayed Price · Currency is USD
0.0020
0.00 (0.00%)
Mar 3, 2026, 11:55 AM EST
Market Cap1.38M +22.6%
Revenue (ttm)3.00K -29.1%
Net Income-226.26K
EPS-0.00
Shares Out691.35M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume341,766
Average Volume1,214,637
Open0.0019
Previous Close0.0020
Day's Range0.0019 - 0.0020
52-Week Range0.0007 - 0.0035
Beta1.74
RSI41.90
Earnings DateFeb 18, 2026

About Pharmagreen Biotech

Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company’s primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products throu... [Read more]

Sector Healthcare
CEO Peter Wojcik
Country United States
Stock Exchange OTCMKTS
Ticker Symbol PHBI
Full Company Profile

Financial Performance

In fiscal year 2024, Pharmagreen Biotech's revenue was $3,410, an increase of 13.74% compared to the previous year's $2,998. Losses were -$1.00 million, 76.6% more than in 2023.

Financial Statements